Cargando…
Tumorigenicity risk of iPSCs in vivo: nip it in the bud
In 2006, Takahashi and Yamanaka first created induced pluripotent stem cells from mouse fibroblasts via the retroviral introduction of genes encoding the transcription factors Oct3/4, Sox2, Klf44, and c-Myc. Since then, the future clinical application of somatic cell reprogramming technology has bec...
Autores principales: | Zhong, Chaoliang, Liu, Miao, Pan, Xinghua, Zhu, Haiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026204/ https://www.ncbi.nlm.nih.gov/pubmed/35692443 http://dx.doi.org/10.1093/pcmedi/pbac004 |
Ejemplares similares
Cargando…
Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)
por: Masotti, Andrea, et al.
Publicado: (2015)
Ejemplares similares
-
Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014) -
iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017) -
Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015) -
The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019) -
iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)